These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1520299)

  • 1. Effect of semi-random mutagenesis at the C-terminal 4 amino acids of human interleukin-6 on its biological activity.
    Yasueda H; Miyasaka Y; Shimamura T; Matsui H
    Biochem Biophys Res Commun; 1992 Aug; 187(1):18-25. PubMed ID: 1520299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding.
    Hammacher A; Ward LD; Weinstock J; Treutlein H; Yasukawa K; Simpson RJ
    Protein Sci; 1994 Dec; 3(12):2280-93. PubMed ID: 7538847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenesis of the human interleukin-6 fourth predicted alpha-helix: involvement of the Arg168 in the binding site.
    Fontaine V; Ooms J; Content J
    Eur J Immunol; 1994 May; 24(5):1041-5. PubMed ID: 8181515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the C-terminus in the activity, conformation, and stability of interleukin-6.
    Ward LD; Hammacher A; Zhang JG; Weinstock J; Yasukawa K; Morton CJ; Norton RS; Simpson RJ
    Protein Sci; 1993 Sep; 2(9):1472-81. PubMed ID: 8401231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of leucine residues in the C-terminal region of human interleukin-6 in the biological activity.
    Nishimura C; Ekida T; Nomura K; Sakamoto K; Suzuki H; Yasukawa K; Kishimoto T; Arata Y
    FEBS Lett; 1992 Oct; 311(3):271-5. PubMed ID: 1327882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a receptor binding site in the carboxyl terminus of human interleukin-6.
    Leebeek FW; Kariya K; Schwabe M; Fowlkes DM
    J Biol Chem; 1992 Jul; 267(21):14832-8. PubMed ID: 1321818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of human/mouse interleukin-6 hybrid proteins: both amino and carboxy termini of human interleukin-6 are required for in vitro receptor binding.
    Fiorillo MT; Cabibbo A; Iacopetti P; Fattori E; Ciliberto G
    Eur J Immunol; 1992 Oct; 22(10):2609-15. PubMed ID: 1396966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saturation mutagenesis of the human interleukin 6 receptor-binding site: implications for its three-dimensional structure.
    Savino R; Lahm A; Giorgio M; Cabibbo A; Tramontano A; Ciliberto G
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4067-71. PubMed ID: 8483922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.
    Toniatti C; Cabibbo A; Sporena E; Salvati AL; Cerretani M; Serafini S; Lahm A; Cortese R; Ciliberto G
    EMBO J; 1996 Jun; 15(11):2726-37. PubMed ID: 8654370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.
    Hideshima T; Chauhan D; Teoh G; Raje N; Treon SP; Tai YT; Shima Y; Anderson KC
    Clin Cancer Res; 2000 Mar; 6(3):1180-9. PubMed ID: 10741750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements for gp80 independence of human herpesvirus 8 interleukin-6 (vIL-6) and evidence for gp80 stabilization of gp130 signaling complexes induced by vIL-6.
    Chen D; Nicholas J
    J Virol; 2006 Oct; 80(19):9811-21. PubMed ID: 16973585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific mutagenesis of human interleukin-6 and its biological activity.
    Nishimura C; Futatsugi K; Yasukawa K; Kishimoto T; Arata Y
    FEBS Lett; 1991 Apr; 281(1-2):167-9. PubMed ID: 2015887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internal deletions of amino acids 29-42 of human interleukin-6 (IL-6) differentially affect bioactivity and folding.
    Arcone R; Fontaine V; Coto I; Brakenhoff JP; Content J; Ciliberto G
    FEBS Lett; 1991 Aug; 288(1-2):197-200. PubMed ID: 1879551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saturation mutagenesis of human interleukin-3.
    Olins PO; Bauer SC; Braford-Goldberg S; Sterbenz K; Polazzi JO; Caparon MH; Klein BK; Easton AM; Paik K; Klover JA
    J Biol Chem; 1995 Oct; 270(40):23754-60. PubMed ID: 7559548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The three carboxy-terminal amino acids of human interleukin-6 are essential for its biological activity.
    Krüttgen A; Rose-John S; Dufhues G; Bender S; Lütticken C; Freyer P; Heinrich PC
    FEBS Lett; 1990 Oct; 273(1-2):95-8. PubMed ID: 2226871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function analysis of murine interleukin 1: biologically active polypeptides are at least 127 amino acids long and are derived from the carboxyl terminus of a 270-amino acid precursor.
    DeChiara TM; Young D; Semionow R; Stern AS; Batula-Bernardo C; Fiedler-Nagy C; Kaffka KL; Kilian PL; Yamazaki S; Mizel SB
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8303-7. PubMed ID: 3022289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carboxy-terminal region of human interleukin-5 is essential for maintenance of tertiary structure but not for dimerization.
    Proudfoot AE; Brown SC; Graber P; Talabot F; Arod CY; Peitsch MC; Banks M; McKinnon M; Solari R; Wells TN
    J Protein Chem; 1996 Jul; 15(5):491-9. PubMed ID: 8895095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding.
    van Dam M; Müllberg J; Schooltink H; Stoyan T; Brakenhoff JP; Graeve L; Heinrich PC; Rose-John S
    J Biol Chem; 1993 Jul; 268(20):15285-90. PubMed ID: 8325898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human IFN-alpha protein engineering: the amino acid residues at positions 86 and 90 are important for antiproliferative activity.
    Hu R; Bekisz J; Schmeisser H; McPhie P; Zoon K
    J Immunol; 2001 Aug; 167(3):1482-9. PubMed ID: 11466368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of site-specific mutations on biologic activities of recombinant human IL-6.
    Snouwaert JN; Kariya K; Fowlkes DM
    J Immunol; 1991 Jan; 146(2):585-91. PubMed ID: 1987278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.